Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.2K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.2K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.4K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.4K
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

1.8K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.8K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

630
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
630

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Preface to special issue on neurodevelopment in Huntington's disease.

Journal of Huntington's disease·2026
Same author

Classical and Emerging Biomarkers in Pyridoxine-Dependent Epilepsy (PDE-ALDH7A1): Implications for Early Diagnosis and Therapeutic Development.

Biomolecules·2026
Same author

Humanized mice carrying a pathogenic GRN deletion as a pre-clinical platform for targeted gene therapies in frontotemporal dementia.

Neurobiology of disease·2026
Same author

Progranulin genetic variant rs5848 displays ancestry-specific associations with Alzheimer's disease.

Human genomics·2026
Same author

Wild-type huntingtin in neurodevelopment.

Journal of Huntington's disease·2026
Same author

MiniPromoters Ple384 (TH) and Ple388 (PITX3) for targeting midbrain dopaminergic neurons in mice and monkeys.

Scientific reports·2026

Related Experiment Video

Updated: Apr 26, 2026

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy
07:21

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy

Published on: June 27, 2025

622

Aquatherapy for neurodegenerative disorders.

Alyson R Plecash1, Blair R Leavitt1

  • 1Centre for Huntington Disease, UBC Hospital and The Centre for Molecular Medicine and Therapeutics and Department of Medical Genetics, Child and Family Research Institute, University of British Columbia, Vancouver, BC, Canada.

Journal of Huntington'S Disease
|July 27, 2014
PubMed
Summary

Aquatherapy offers a safe exercise environment for neurodegenerative disorders. Current evidence supports its use in Parkinson's disease and multiple sclerosis, but more research is needed for others.

Keywords:
Amyotrophic lateral sclerosisChoreaHuntingtonHuntington choreaHuntington('s) diseaseLou Gehrig's diseaseMultiple sclerosisParkinsonParkinson('s) diseaseaquatherapyaquatic therapyhydrotherapypool therapy

More Related Videos

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
05:54

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials

Published on: May 10, 2024

2.4K

Related Experiment Videos

Last Updated: Apr 26, 2026

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy
07:21

Electroencephalographic Signal Acquisition Framework for Neurodiverse: A Case Study of Dolphin-Assisted Therapy

Published on: June 27, 2025

622
Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials
05:54

Author Spotlight: Exploring Acupuncture in Alzheimer's Research from Thread-Embedding Techniques to Clinical Trials

Published on: May 10, 2024

2.4K

Area of Science:

  • Neurology
  • Rehabilitation Medicine
  • Hydrotherapy

Background:

  • Aquatherapy utilizes water's properties for therapeutic exercise and rehabilitation.
  • It offers a safe and adaptable environment for individuals with special needs.
  • Neurodegenerative disorders present unique challenges for physical activity and rehabilitation.

Purpose of the Study:

  • To review the efficacy of aquatherapy programs for four specific neurodegenerative disorders.
  • To evaluate the current evidence supporting aquatherapy in Parkinson's disease, multiple sclerosis, amyotrophic lateral sclerosis, and Huntington's disease.

Main Methods:

  • Systematic review of existing literature on aquatherapy interventions.
  • Analysis of studies focusing on Parkinson's disease, multiple sclerosis, ALS, and Huntington's disease.

Main Results:

  • Aquatherapy demonstrates positive outcomes and support for individuals with Parkinson's disease.
  • Evidence suggests benefits of aquatherapy for individuals with multiple sclerosis.
  • Further research is required to establish definitive recommendations for ALS and Huntington's disease.

Conclusions:

  • Aquatherapy is a beneficial therapeutic modality for Parkinson's disease and multiple sclerosis.
  • Additional high-quality studies are necessary to confirm the effectiveness of aquatherapy for amyotrophic lateral sclerosis and Huntington's disease.
  • Aquatherapy holds potential as a rehabilitative tool across a spectrum of neurodegenerative conditions.